Back to Trades
Sell4
GeneDx Holdings Corp.
WGS
Total Value
$1.3M
Net $1.3M sold
Sales
$1.3M
1 transaction
Company Information
- Company Name
- GeneDx Holdings Corp.
- Ticker Symbol
- WGS
- CIK
- 0001818331
Insider Information
- Role
- Insider
- Location
- STAMFORD, CT
Filing Details
- Filing Date
- Sep 18, 2025
- Transaction Date
- Sep 16, 2025
- Accession Number
- 0001689575-25-000003
- Form Type
- 4
- Net Trading Amount
- -$1.3M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 16, 2025 | Class A Common Stock | 18,750 | — | Exercise | — |
| Sep 16, 2025 | Class A Common Stock | 10,501 | $121.47 | Sale | $1.3M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Sep 16, 2025 | Derivative | 18,750 | — | Exercise | — |
Footnotes
- (F1)Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- (F2)The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- (F3)The price reported is a weighted average price. These shares were sold as part of a block trade for multiple security holders of the Issuer in multiple transactions at prices ranging from $118.28 to $123.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 with regard to the block trade.
- (F4)Following the reported sales, in addition to the 14,578 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units ("RSUs") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms.
- (F5)6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.